139 related articles for article (PubMed ID: 8845470)
1. Idiopathic chronic DIC controlled with low-molecular-weight heparin.
Majumdar G
Blood Coagul Fibrinolysis; 1996 Jan; 7(1):97-8. PubMed ID: 8845470
[TBL] [Abstract][Full Text] [Related]
2. Successful Treatment with Edoxaban for Disseminated Intravascular Coagulation in a Case of Aortic Dissection Complicated with Immune Thrombocytopenic Purpura.
Uemura S; Kobayashi H; Seki Y; Okoshi Y; Sone H; Nomoto N
Intern Med; 2020 Aug; 59(16):2035-2039. PubMed ID: 32389942
[TBL] [Abstract][Full Text] [Related]
3. [Long-term treatment with low molecular weight heparin, of chronic disseminated intravascular coagulation].
García Fernández JR; López Berenguel F; Ais C
An Med Interna; 2003 Apr; 20(4):191-4. PubMed ID: 12768833
[TBL] [Abstract][Full Text] [Related]
4. Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation.
Slofstra SH; van 't Veer C; Buurman WA; Reitsma PH; ten Cate H; Spek CA
Crit Care Med; 2005 Jun; 33(6):1365-70. PubMed ID: 15942357
[TBL] [Abstract][Full Text] [Related]
5. [The treatment with low-molecular-weight heparin of disseminated intravascular coagulation secondary to an aortic aneurysm].
Callejas Rubio JL; Ortego Centeno N; Díez Ruiz A; Bermúdez García JM
Rev Clin Esp; 1998 Nov; 198(11):781-2. PubMed ID: 9883061
[No Abstract] [Full Text] [Related]
6. [A case of recurrent rectal cancer with idiopathic thrombocytopenic purpura showing rapid progression, suggesting disseminated intravascular coagulopathy].
Ohira G; Miyauchi H; Tohma T; Kuboshima M; Yoneyama Y; Matsubara H
Gan To Kagaku Ryoho; 2012 Jan; 39(1):139-42. PubMed ID: 22241370
[TBL] [Abstract][Full Text] [Related]
7. Use of low molecular weight heparin and aminocaproic acid in chronic DIC associated with prostate cancer--a case report.
Shirai K; Chaudhary UB
ScientificWorldJournal; 2007 Feb; 7():753-5. PubMed ID: 17619757
[TBL] [Abstract][Full Text] [Related]
8. Chronic idiopathic thrombocytopenic purpura complicated by chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.
Minemura N; Matsushima T; Takagi C; Sadakata H; Tamura J; Sawamura M; Murakami H; Naruse T; Tsuchiya J
Acta Haematol; 1993; 90(1):39-41. PubMed ID: 8237272
[TBL] [Abstract][Full Text] [Related]
9. The course of disseminated intravascular coagulation is predicted by changes in thrombin-antithrombin III complex levels--is there any difference between treatment with standard heparin or low-molecular-weight heparin?
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):623-7. PubMed ID: 1664251
[TBL] [Abstract][Full Text] [Related]
10. Expert consensus for the treatment of disseminated intravascular coagulation in Japan.
Wada H; Asakura H; Okamoto K; Iba T; Uchiyama T; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S; Kushimoto S; Seki Y; Madoiwa S; Maruyama I; Yoshioka A;
Thromb Res; 2010 Jan; 125(1):6-11. PubMed ID: 19782389
[TBL] [Abstract][Full Text] [Related]
11. [Heparin, low molecular weight heparin, heparinoid, and antithrombin III therapy of disseminated intravascular coagulation].
Nakagawa M
Nihon Rinsho; 1993 Jan; 51(1):87-92. PubMed ID: 7679453
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of low molecular weight heparin in a canine model of thromboplastin-induced acute disseminated intravascular coagulation.
Mischke R; Fehr M; Nolte I
Res Vet Sci; 2005 Aug; 79(1):69-76. PubMed ID: 15894027
[TBL] [Abstract][Full Text] [Related]
13. What is the best heparin to treat sepsis with?
van Roessel S; van der Laan AM; de Pont AC
Crit Care Med; 2015 Jun; 43(6):e212-3. PubMed ID: 25978176
[No Abstract] [Full Text] [Related]
14. [Treatment of disseminated intravascular coagulation].
Asakura H
Rinsho Ketsueki; 1990 Jun; 31(6):756-62. PubMed ID: 2214166
[TBL] [Abstract][Full Text] [Related]
15. Should heparin be used to treat patients with severe sepsis?
Kalil AC
Crit Care Med; 2015 Mar; 43(3):694-5. PubMed ID: 25700050
[No Abstract] [Full Text] [Related]
16. Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.
Asakura H; Sano Y; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
Intensive Care Med; 2004 Oct; 30(10):1950-5. PubMed ID: 15480547
[TBL] [Abstract][Full Text] [Related]
17. The authors reply.
Zarychanski R; Kumar A
Crit Care Med; 2015 Jun; 43(6):e213. PubMed ID: 25978177
[No Abstract] [Full Text] [Related]
18. Gabexate as a therapy for disseminated intravascular coagulation.
Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
[TBL] [Abstract][Full Text] [Related]
19. Successful long-term management of aneurysm-associated chronic disseminated intravascular coagulation with low molecular weight heparin.
Perry JH; Lazar HL; Quillen K; Sloan JM
J Card Surg; 2012 Nov; 27(6):730-5. PubMed ID: 23173861
[TBL] [Abstract][Full Text] [Related]
20. Heparins in sepsis-induced disseminated intravascular coagulation: low weight-high impact?
Lehmann C; Usichenko TI; Pavlovic D
Crit Care Med; 2005 Jun; 33(6):1455-7. PubMed ID: 15942389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
